# CNXU (Conexeu Sciences Inc.) - SEC EDGAR Financial Statements

> Conexeu Sciences Inc. reported $7.16M in total assets through July 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CNXU
- Markdown: https://convexityos.com/fundamentals/CNXU.md
- SEC CIK: 0002066836
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002066836&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jul 31, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | $1.97M | Total debt: $72K |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jul 2025 | Apr 2025 |
| --- | --- | --- | --- | --- |
| Research & Development | $270K | $67K | $135K | $42K |
| Total Operating Expenses | $7.69M | $2.38M | $1.30M | $457K |
| **Operating Income** | -$7.69M | -$2.38M | -$1.30M | -$457K |
| **EBITDA** | -$7.68M | -$2.37M | -$1.29M | -$454K |
| Interest Income | $34K | $84K | $386 | $0 |
| Interest Expense | $0 | $0 | -$43 | $1.4K |
| Income Before Tax | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| **Net Income** | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Basic EPS | -$0.29 | -$0.11 | -$0.09 | -$0.05 |
| **Diluted EPS** | -$0.29 | -$0.11 | -$0.09 | -$0.05 |
| Basic Shares Outstanding | 27.0M | 20.6M | 14.1M | 9.5M |
| Diluted Shares Outstanding | 27.0M | 20.6M | 14.1M | 9.5M |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Oct 2025 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.97M | $6.85M | $4.81M |
| **Cash & Short-Term Investments** | $1.97M | $6.85M | $4.81M |
| **Total Current Assets** | $6.76M | $7.91M | $7.46M |
| Property, Plant & Equipment, Net | $74K | $38K | $11K |
| Intangible Assets | $164K | $164K | $177K |
| **Total Non-Current Assets** | $400K | $286K | $230K |
| **Total Assets** | $7.16M | $8.20M | $7.69M |
| **Total Current Liabilities** | $1.27M | -- | $336K |
| **Total Non-Current Liabilities** | $33K | -- | $0 |
| **Total Liabilities** | $1.31M | $1.00M | $336K |
| **Total Debt (incl. Leases)** | $72K | -- | -- |
| Common Stock | $27K | $21K | $19K |
| Retained Earnings | -$16.27M | -$8.54M | -$4.52M |
| **Total Stockholders' Equity** | $5.85M | $7.20M | $7.35M |
| Total Equity | $5.85M | $7.20M | $7.35M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jul 2025 | Apr 2025 |
| --- | --- | --- | --- | --- |
| Net Income | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Depreciation & Amortization | $5.4K | $11K | $6.6K | $3.4K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jul 2025 | Apr 2025 |
| --- | --- | --- | --- | --- |
| Current Ratio | 5.31x | -- | -- | -- |
| Quick Ratio | 1.55x | -- | -- | -- |
| Debt to Equity | 0.01x | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
